Boston Scientific Corp (BSX)

Cash ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Cash and cash equivalents US$ in thousands 865,000 952,000 426,000 570,000 928,000 338,000 276,000 325,000 1,925,000 1,947,000 2,675,000 2,016,000 1,734,000 2,022,000 1,724,000 370,000 217,000 277,000 123,000 139,000
Short-term investments US$ in thousands 4,000 4,000 2,000 3,000 5,000 8,000 10,000 4,000 176,000 213,000 414,000 0 0 0 1,000 1,000 1,000
Total current liabilities US$ in thousands 4,933,000 4,579,000 4,562,000 4,083,000 3,803,000 3,549,000 3,883,000 4,275,000 4,274,000 4,022,000 4,073,000 3,393,000 3,681,000 3,302,000 3,108,000 3,976,000 4,866,000 4,254,000 4,850,000 4,479,000
Cash ratio 0.18 0.21 0.09 0.14 0.24 0.10 0.07 0.08 0.45 0.49 0.70 0.66 0.58 0.61 0.55 0.09 0.04 0.07 0.03 0.03

December 31, 2023 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($865,000K + $—K) ÷ $4,933,000K
= 0.18

The cash ratio of Boston Scientific Corp. has fluctuated over the past eight quarters, with values ranging from 0.30 to 0.47. The cash ratio measures a company's ability to cover its short-term liabilities with its available cash and cash equivalents.

The trend in the cash ratio indicates that Boston Scientific Corp. maintains a relatively stable level of cash compared to its current liabilities. A decrease in the cash ratio may indicate potential liquidity concerns, while an increase may reflect a strengthened liquidity position.

In Q4 2022, the cash ratio was the highest at 0.47, indicating a relatively strong ability to cover short-term obligations with its cash holdings. However, in Q2 2023, the cash ratio decreased to 0.30, signaling a potential reduction in liquidity compared to the previous quarters.

Overall, while the company's cash ratio has shown fluctuations, it is crucial to monitor this ratio over time to assess Boston Scientific Corp.'s liquidity position and ability to meet its short-term financial obligations.


Peer comparison

Dec 31, 2023


See also:

Boston Scientific Corp Cash Ratio (Quarterly Data)